BioSpace News Archive

Innovent and Lilly Release Clinical Trial Results of Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous NSCLC in an Oral Presentation at IASLC WCLC 2020

Innovent Biologics, Inc. announced with Eli Lilly and Company that interim analysis data from ORIENT-11 were released today in an oral presentation at the IASLC World Conference on Lung Cancer 2020 Virtual Presidential Symposium.

August 8, 2020
·
9 min read
Policy

Statement from the Chief Public Health Officer of Canada on August 8, 2020

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

August 8, 2020
·
2 min read
BioMidwest

Lung cancer researchers present new clinical trial data at International Association for the Study of Lung Cancer World Conference on Lung Cancer Virtual Presidential Symposium

CheckMate 743 Shows That Dual Immunotherapy, Nivolumab + Ipilimumab, Improves Overall Survival for Patients with Previously Untreated Mesothelioma

August 8, 2020
·
7 min read
Drug Development

Rapid Seropositivity Test Monitors Immune Response to SARS-CoV-2

Cayman scientists have developed a SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit to enable semi-quantitative identification of neutralizing antibodies in human plasma or serum to the novel coronavirus that causes COVID-19.

August 8, 2020
·
2 min read
Pharm Country

Opdivo® (nivolumab) Plus Yervoy® (ipilimumab) Demonstrates Durable Survival Benefit vs. Chemotherapy in Patients with Previously Untreated Malignant Pleural Mesothelioma

CheckMate -743 is the first and only Phase 3 trial in which first-line immunotherapy treatment improved survival in patients with malignant pleural mesothelioma

August 8, 2020
·
34 min read